○Hidekazu Yamazaki1, Masafumi Morimoto2, Chiyoe Hikita2, Mitsuhiro Iwasaki2, Masahiro Maeda2, Yasufumifumi Inaka2, Shinya Fukuta2, Hiroaki Satou2, Yasuhide Tsuda1,3 (1.Department of Neurology and Neuroendovascular Treatment, Yokohama Shintoshi Neurosurgical Hospital, Japan, 2.Department of Neurosurgery, Yokohama Shintoshi Neurosurgical Hospital, 3.Department of Cardiology, Yokohama Shintoshi Neurosurgical hospital)
Session information
Oral Session
[O-32] Oral Session 32 Cerebrovascular disease4
Fri. May 21, 2021 9:45 AM - 11:15 AM Room 09 (ICC Kyoto 1F Sakura Hall)
Chair:Hoshino Haruhiko(Department of Neurology, Tokyo Saiseikai Central Hospital)
○Yuhei Anan, Tadashi Ozawa, Misato Ozawa, Masayuki Suzuki, Kumiko Miura, Kosuke Matsuzono, Takafumi Mashiko, Reiji Koide, Ryota Tanaka, Shigeru Fujimoto (Division of Neurology, Department of Medicine, Jichi Medical University, Japan)
○Takafumi Mashiko, Kumiko Miura, Yuhei Anan, Kosuke Matsuzono, Tadashi Ozawa, Reiji Koide, Ryota Tanaka, Shigeru Fujimoto (Division of Neurology, Department of Internal Medicine, Jichi Medical University, Japan)
○Kentaro Yoshida, Naoki Tokuda, Yutaka Suto, Hiroki Fukuda (the Department of Neurology, Japanese Red Cross Matsue Hospital, Japan)
○Hidetaka Mitsumura, Tomotaka Shiraishi, Tomomichi Kitagawa, Maki Tanabe, Takeo Sato, Hiroki Takatsu, Teppei Komatsu, Kenichiro Sakai, Tadashi Umehara, Shusaku Omoto, Hidetomo Murakami, Yasuyuki Iguchi (Department of Neurology, The Jikei University School of Medicine, Japan)
○Ayane Ohyama1, Ryosuke Doijiri1, Takuji Sonoda1, Kohei Takikawa1, Naoya Yamazaki1, Mitsunobu Sato1, Momoyo Oda2, Ken Takahashi1, Hiroaki Takahashi1, Takahiko Kikuchi1 (1.Department of Neurology, Iwate Prefectural Central Hospital, Japan, 2.Department of Rehabilitation, Iwate Prefectural Central Hospital)